Biggest News Aggregation in the World
📰 Chris Pak News

Page 2 - Chris Pak News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Chris Pak. Real-time updates on events, politics, business and more.

Molecular Targeting Technologies, Inc. and University of Antwerp Begin First-in-Human Study of TDURA Diagnostic for Early Detection of Response to Colon Cancer Therapy

Published: May 11, 2021     WEST CHESTER, Pa.--(BUSINESS WIRE)-- Molecular Targeting Technologies, Inc.   (MTTI) and University of Antwerp today announced the approval of a Clinical Trial Application by the European Federal Agency for Medicines and Health Products (FAMHP) (equivalent to a US IND). The clinical study will evaluate the safety, dosimetry and treatment response of TDURA ( 99mTc-Duramycin), in patients with advanced colorectal cancer (CRC)*. Colorectal cancer is the third mo...
United States Sigrid Stroobants Chris Pak Molecular Targeting Technologies Inc European Federal Agency For Medicines Nuclear Medicine

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.

Press release content from Business Wire. The AP news staff was not involved in its creation. FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc. March 2, 2021 GMT WEST CHESTER, Pa.--(BUSINESS WIRE)--Mar 2, 2021-- Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced today the approval of an Investigational New Drug (IND) application by th...
United States Chris Pak Clinical Research Organization Newtown Molecular Targeting Technologies Inc National Institutes Of Health Drug Administration
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science